Oragenics, Inc.

Contributing Author

Recent Articles by Oragenics, Inc.

Feb-09	Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy OGEN -5.18% GlobeNewswire
Feb-03	Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program OGEN -7.23% GlobeNewswire
Feb-02	Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care OGEN GlobeNewswire
Jan-14	Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico OGEN GlobeNewswire